Envoy Medical Reports Full Year 2025 Financial ResultsReceived FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing...
Envoy Medical Regains Compliance with Nasdaq Listing RequirementWhite Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (
NASDAQ: COCH) ("Envoy Medical" or the "Company"),...
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing SpaceWhite Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (
NASDAQ: COCH) ("Envoy Medical" or the "Company"),...
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical TrialFinancing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy Medical shareholder, billionaire Glen Taylor...
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds upon the exercise in full...
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public OfferingWhite Bear Lake, Minnesota--(Newsfile Corp. - February 11, 2026) - Envoy Medical® Inc. (
NASDAQ: COCH) ("Envoy Medical" or the "Company"),...
Small Cap Growth Virtual Investor Conference Agenda Announced for February 5thCompany Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5WHITE BEAR LAKE, Minn., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Envoy Medical® Inc. (
NASDAQ: COCH) (“Envoy Medical” or the “Company”), a hearing health company pioneering fully implanted hearing solutions, today announced that management will participate in the Small Cap Growth Virtual Investor Conference on February 5, 2026.
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear ImplantWhite Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical® Inc. (
NASDAQ: COCH) ("Envoy Medical" or the "Company"),...
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant PatientWhite Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical® Inc. (
NASDAQ: COCH) ("Envoy Medical" or the "Company"),...
Envoy Medical Announces the Grant of Its 40th U.S. PatentWhite Bear Lake, Minnesota--(Newsfile Corp. - December 2, 2025) - Envoy Medical® Inc. (
NASDAQ: COCH) ("Envoy Medical" or the "Company"),...
Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical TrialWhite Bear Lake, Minnesota--(Newsfile Corp. - November 18, 2025) - Envoy Medical® Inc. (
NASDAQ: COCH) ("Envoy Medical" or the "Company"),...
Envoy Medical Reports Third Quarter 2025 Financial and Operational ResultsWhite Bear Lake, Minnesota--(Newsfile Corp. - November 10, 2025) - Envoy Medical®, Inc. (
NASDAQ: COCH) ("Envoy Medical" or the "Company"),...
AI & Technology Virtual Investor Conference: Presentations Now Available for Online ViewingCompany Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Envoy Medical Receives Positive Listing Determination from NASDAQWhite Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2025) - Envoy Medical, Inc. (
NASDAQ: COCH) ("Envoy Medical" or the "Company"),...
AI & Technology Virtual Investor Conference Agenda Announced for October 28thCompany Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
